![irc 83 irc 83](https://kurtzcpa.com/wp-content/uploads/2015/11/taxgraph3.png)
The states with the highest percentage of the population immunized (with a second dose or a single dose) are Mato Grosso do Sul (41.32%), São Paulo (33.71%), Rio Grande do Sul (32.90%), Espírito Santo (29.31%) and Santa Catarina (27.74%). In Brazil, between Monday and Tuesday alone, the first dose was applied to 1,150,057 people, the second to 877,064 and the single dose to 3,862, for a total of 2,030,983 doses applied in one day. According to the study carried out by a consortium of media outlets and which was released Tuesday evening, 56,820,544 doses were applied of both the second dose and the monodose drug, which made up for 26.83% of Brazilians, while 59.19% of the population, or 125,339,734 people, had been given at least the initial part of the treatment. Uruguay's Minister of Public Health Daniel Salinas boasted these results on social media.Ī Brazilian survey showed that between the first and second dose as well as the monodose drug combined, 181,283,214 doses had been applied in the country since the beginning of vaccination. In addition to that, 233,220 people who were given CoronaVac or AstraZeneca have already received a third dose, this time of Pfizer, while 328,769 others are scheduled to do so shortly.
IRC 83 FULL
MSP sources said 2,480,237 of 3,542,025 inhabitants in Uruguay had already been inoculated with the two doses since March 1, while more than 56 million people in Brazil had taken the necessary doses.Īccording to these figures, 70% of Uruguay's population has already achieved full immunization or is on the way to achieving it, which is said to happen 14 days after innoculation, 168,414 people have already received the first dose and are waiting for the second.
![irc 83 irc 83](https://www.jyotirubber.com/wp-content/uploads/2021/01/bridge-bearing-pads.jpg)
Uruguay's Public Health Ministry (MSP) Tuesday announced 70% of the population had already received two doses of COVID-19 vaccines such as CoronaVac, Pfizer or AstraZeneca, while a private survey showed only 26.83% of Brazilians were at the same level. Photo: A nurse carries a batch of Pfizer vaccines in San José, Uruguay (Sebastián Astorga/MERCOPRESS)